ReBio Technologies

About:

ReBio Technologies, a biotech company, specializes in developing proprietary routes to key commodity platform biochemicals.

Website: https://rebiopharma.com/

Top Investors: Business Finland, WI Harper Group, Kinled Holding

Description:

ReBio Technologies is an industrial biotechnology company that specializes in the developing proprietary routes to key commodity platform biochemicals from renewable resources. It also develops tools in biotechnology to elucidate and design new biosynthetic pathways in a range of microbial hosts, for the efficient and cost-effective production of high-value chemicals through fermentation. This, coupled with state-of-the-art polymer technology, provides manufacturing industries with innovative solutions to their raw material requirements. It was founded in 2014 and is headquartered in Cranleigh, Surrey, United Kingdom.

Total Funding Amount:

$5.46M

Headquarters Location:

Cranleigh, Surrey, United Kingdom

Founded Date:

2014-01-01

Contact Email:

info(AT)rebio.co.uk

Founders:

Jonathan Glen

Number of Employees:

11-50

Last Funding Date:

2020-01-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai